Crinetics Pharmaceuticals, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.59M2.04M2.43M1.19M0.07M1.08M4.74M4.01M1.04M
Gross Profit 0.59M2.04M2.43M1.19M0.07M1.08M4.74M4.01M1.04M
Operating items
Research & Development 5.10M9.23M24.48M41.51M57.00M84.25M130.22M168.53M240.16M
Selling, General & Administrative 1.53M1.94M6.66M13.52M18.03M24.52M42.39M58.09M99.74M
Operating Expenses 6.63M11.17M31.14M55.02M75.02M108.78M172.62M226.62M339.89M
Operating Income -6.04M-9.13M-28.71M-53.83M-74.95M-107.70M-167.88M-222.61M-338.85M
EBIT -6.04M-9.13M-28.71M-53.83M-74.95M-107.70M-167.88M-222.61M-338.85M
Non-operating items
Interest & Investment Income 0.04M0.03M1.75M3.46M0.99M0.16M4.32M13.44M41.44M
Non Operating Income 0.03M0.06M1.59M3.41M1.14M-0.10M4.97M13.28M40.92M
Net income details
EBT -6.02M-9.11M-26.96M-50.37M-73.96M-107.55M-163.56M-209.17M-297.42M
Profit After Tax -6.02M-9.16M-27.11M-50.42M-73.81M-107.64M-163.92M-214.53M-298.41M
Equity Income -1.01M-5.20M-0.47M
Income from Continuing Operations -6.02M-9.11M-26.96M-50.37M-73.96M-107.55M-163.56M-209.17M-297.42M
Consolidated Net Income -6.02M-9.11M-26.96M-50.37M-73.96M-107.55M-163.56M-209.17M-297.42M
Income towards Parent Company -6.02M-9.11M-26.96M-50.37M-73.96M-107.55M-163.56M-209.17M-297.42M
Net Income towards Common Stockholders -6.02M-9.11M-26.96M-50.37M-73.96M-107.55M-163.56M-209.17M-297.42M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 24.04M24.22M32.92M47.50M53.81M66.80M92.74M
Shares Outstanding (Diluted Average) 30.45M38.44M51.98M58.07M80.78M
EBITDA -6.02M-9.16M-27.05M-50.34M-73.94M-108.05M-167.47M-209.62M-298.42M
Shares Outstanding 1.17M1.55M24.06M24.26M33.00M47.60M53.88M68.17M92.93M